Vilanterol Trifenatate
Vilanterol trifenatate is the triphenylacetate salt of vilanterol, an ultra-long-acting beta-2 agonist (LABA) used for maintenance therapy of asthma and COPD in combination with other agents. The trifenatate salt form is used in the inhaled powder formulations marketed for once-daily maintenance bronchodilation. Like the free base, it provides >24 hours of beta-2 receptor-mediated bronchial smooth muscle relaxation.
Molecular Weight
774.8000 g/mol
TPSA
128.00 Ų
Therapeutic Areas
Pharmacokinetics (PK)
Pharmacodynamics (PD)
2D Structure
Cite this structure
Embed this structure
SMILES
O=C(O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O
InChI
InChI=1S/C24H33Cl2NO5.C20H16O2/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;21-19(22)20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h5-9,14,24,27-30H,1-4,10-13,15-17H2;1-15H,(H,21,22)/t24-;/m0./s1
Molecular Formula
C44H49Cl2NO7
HBD / HBA
5 / 8
Rotatable Bonds
20
Heavy Atoms
54
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Frequently Asked Questions
Vilanterol trifenatate is the triphenylacetate salt of vilanterol, an ultra-long-acting beta-2 agonist (LABA) used for maintenance therapy of asthma and COPD in combination with other agents. The trifenatate salt form is used in the inhaled powder formulations marketed for once-daily maintenance bronchodilation. Like the free base, it provides >24 hours of beta-2 receptor-mediated bronchial smooth muscle relaxation.
Yes, Vilanterol Trifenatate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1084172. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 44482554. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="vilanterol-trifenatate"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/vilanterol-trifenatate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/vilanterol-trifenatate/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/vilanterol-trifenatate/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="vilanterol-trifenatate"></drugfyi-drug>